Short answer
Pulmonx Corp (LUNG) filed an 8-K current report with the SEC on March 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 and full-year 2025 results announced March 4, 2026: full figures in Exhibit 99.1.
Pulmonx Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 results announced March 4, 2026: full figures in Exhibit 99.1
- Pulmonx (LUNG) is a small-cap medical device company focused on bronchoscopic lung volume reduction treatments
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Pulmonx Corp 8-K filings
Get the next LUNG 8-K as it lands
Follow LUNG for push alerts, or ask the research agent what this filing means.